Gujarat Themis Biosyn Ltd

Fri 23/10/2026,14:34:58 | NSE : GUJTHEM

₹325.10-28.30 (-8.01%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 348.85

Previous Close

₹ 353.40

Volume

343646

Mkt Cap ( ₹ Cr)

₹ 4231.23

High

₹ 353.95

Low

₹ 323.25

52 Week High

₹ 479.00

52 Week Low

₹ 225.05

Book Value Per Share

₹ 23.12

Dividend Yield

0.18

Face Value

₹ 1.00

What's Your Call?

Collective community sentiment on Gujarat Themis Biosyn Ltd

Your Vote -

Buy

88.24%

Hold

0.00%

Sell

11.76%

88.24%

17 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

37%

Sell Order Quantity

63%

Bid Price

Qty

314.65

66

315.00

167

315.00

38

314.00

167

314.00

1

Bid Total

38601

Bid Price

Qty

314.95

34

315.00

1740

315.00

43

315.00

21

315.00

18

Bid Total

65149

Option Chain

Analyzes market sentiment, predicts Gujarat Themis Biosyn Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Guj. Themis Bios has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2026

    19 Oct 2026, 4:40PM As of September 2026, 59.33% is owned by Indian Promoters and 40.67% by Public. <p align=justify> Institutional holds 16.45% (Insurance Companies 2.17
  • Guj. Themis Bios - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    12 Oct 2026, 5:34PM Gujarat Themis Biosyn Limited has informed the Exchange about Certificate under 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for t
  • Guj. Themis Bios - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    12 Oct 2026, 5:23PM Kindly refer to the RTA compliance Certificate for the quarter ended 30.09.2026.
  • Guj. Themis Bios - Credit Rating

    9 Oct 2026, 12:01PM Gujarat Themis Biosyn Limited has informed the Exchange about Credit Rating
  • Guj. Themis Bios - Shareholders meeting

    1 Oct 2026, 12:51PM Scrutinizer's Report of 45th Annual General Meeting of the Company counter signed by the Chairman.
  • Guj. Themis Bios - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    1 Oct 2026, 12:36PM Please refer to our counter signed Scrutinizer's Report of 45th Annual General Meeting.
  • Guj. Themis Bios - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Sep 2026, 8:48PM Kindly refer to the attachment.
  • Guj. Themis Bios - Shareholders meeting

    30 Sep 2026, 8:46PM Gujarat Themis Biosyn Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2026. Further, the
  • Guj. Themis Bios - Shareholders meeting

    30 Sep 2026, 8:12PM Revised outcome of 45th Annual General Meeting of the Company due to typographical error.
  • Guj. Themis Bios - Shareholder Meeting / Postal Ballot-Outcome of AGM

    30 Sep 2026, 8:08PM Please refer to our revised outcome of the Annual General Meeting due to typographical error.
  • Guj. Themis Bios - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association

    30 Sep 2026, 6:19PM Please refer to the Intimation of amendment to Articles of Association of the Company.
  • Guj. Themis Bios - Amendment to AOA/MOA

    30 Sep 2026, 6:14PM Gujarat Themis Biosyn Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company.
  • Guj. Themis Bios - Shareholders meeting

    30 Sep 2026, 5:45PM Gujarat Themis Biosyn Limited has informed the Exchange regarding Outcome of Annual General Meeting held on September 30, 2026
  • Guj. Themis Bios - Shareholders meeting

    30 Sep 2026, 12:33PM Gujarat Themis Biosyn Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2026
  • Guj. Themis Bios - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    1 Oct 2026, 12:36PM Please refer to our counter signed Scrutinizer's Report of 45th Annual General Meeting.
  • Guj. Themis Bios - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Sep 2026, 8:48PM Kindly refer to the attachment.
  • Guj. Themis Bios - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    1 Oct 2026, 12:36PM Please refer to our counter signed Scrutinizer's Report of 45th Annual General Meeting.
  • Guj. Themis Bios - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Sep 2026, 8:48PM Kindly refer to the attachment.
  • Guj. Themis Bios - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    1 Oct 2026, 12:36PM Please refer to our counter signed Scrutinizer's Report of 45th Annual General Meeting.
  • Guj. Themis Bios - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Sep 2026, 8:48PM Kindly refer to the attachment.
  • Guj. Themis Bios - Shareholder Meeting / Postal Ballot-Outcome of AGM

    30 Sep 2026, 5:37PM Please refer to the outcome of 45th Annual General Meeting held on 30.09.2026
  • Guj. Themis Bios - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    1 Oct 2026, 12:36PM Please refer to our counter signed Scrutinizer's Report of 45th Annual General Meeting.
  • Guj. Themis Bios - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Sep 2026, 8:48PM Kindly refer to the attachment.
  • Guj. Themis Bios - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    1 Oct 2026, 12:36PM Please refer to our counter signed Scrutinizer's Report of 45th Annual General Meeting.
  • Guj. Themis Bios - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Sep 2026, 8:48PM Kindly refer to the attachment.
  • Guj. Themis Bios - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    1 Oct 2026, 12:36PM Please refer to our counter signed Scrutinizer's Report of 45th Annual General Meeting.
  • Guj. Themis Bios - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Sep 2026, 8:48PM Kindly refer to the attachment.
  • Guj. Themis Bios - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    1 Oct 2026, 12:36PM Please refer to our counter signed Scrutinizer's Report of 45th Annual General Meeting.
  • Guj. Themis Bios - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    1 Oct 2026, 12:36PM Please refer to our counter signed Scrutinizer's Report of 45th Annual General Meeting.
  • Guj. Themis Bios - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Sep 2026, 8:48PM Kindly refer to the attachment.
  • Guj. Themis Bios - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Sep 2026, 8:48PM Kindly refer to the attachment.
  • Guj. Themis Bios - Trading Window

    23 Sep 2026, 6:55PM Gujarat Themis Biosyn Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulat
  • Guj. Themis Bios - Copy of Newspaper Publication

    23 Sep 2026, 2:48PM Gujarat Themis Biosyn Limited has informed the Exchange about Copy of Newspaper Publication for Corrigendum to the Notice of 45th Annual General Meeti
  • Guj. Themis Bios has declared 67% Final dividend for the financial year March 2026

    23 Sep 2026, 7:00AM Gujarat Themis Biosyn Ltd. on Monday, 25 May 2026, has announced Final dividend of 67 percent on Equity Share, to its shareholders holding shares on t
  • Guj. Themis Bios - Shareholders meeting

    21 Sep 2026, 8:58PM Gujarat Themis Biosyn Limited has informed the Exchange regarding Corrigendum to the Notice of Annual General Meeting.
  • Guj. Themis Bios - Corrigendum To The Notice Of Annual General Meeting.

    21 Sep 2026, 8:54PM Please refer to the attachment.
  • Guj. Themis Bios - General Updates

    18 Sep 2026, 4:48PM Gujarat Themis Biosyn Limited has informed the Exchange about General Updates on Record Date for the Dividend for FY 2025-26.
  • Guj. Themis Bios - Corporate Action-Fixed Record Date For Dividend For FY 2025-26

    18 Sep 2026, 4:38PM Kindly refer to the attachment.
  • Guj. Themis Bios - General Updates

    18 Sep 2026, 10:39AM Gujarat Themis Biosyn Limited has informed the Exchange about Acquisition
  • Guj. Themis Bios - Announcement under Regulation 30 (LODR)-Updates on Acquisition

    18 Sep 2026, 10:31AM Please refer to the attachment.
  • Guj. Themis Bios - General Updates

    16 Sep 2026, 7:48PM Gujarat Themis Biosyn Limited has informed the Exchange about General Updates
  • Guj. Themis Bios - Announcement under Regulation 30 (LODR)-Allotment

    16 Sep 2026, 7:24PM Please refer to the Disclosure under Reg 30 of LODR.
  • Guj. Themis Bios has submitted to BSE the Shareholding Pattern for the Period Ended August 28, 2026

    11 Sep 2026, 6:32PM As of August 2026, 59.33% is owned by Indian Promoters and 40.67% by Public. <p align=justify> Institutional holds 18.72% (Insurance Companies 2.17%)
  • Guj. Themis Bios - Outcome of Board Meeting

    10 Sep 2026, 7:41PM Gujarat Themis Biosyn Limited has informed the Exchange regarding Outcome of Board Meeting held on September 10, 2026.
  • Guj. Themis Bios - Board Meeting Outcome for Outcome Of The Board Meeting Held On 10.09.2026

    10 Sep 2026, 7:37PM Please refer to the Outcome of the Board meeting held on 10.09.2026
  • Guj. Themis Bios - Addendum To The Notice Of 45Th Annual General Meeting ('AGM')

    8 Sep 2026, 8:17PM Please refer to the attachment
  • Guj. Themis Bios - Shareholders meeting

    8 Sep 2026, 8:12PM Gujarat Themis Biosyn Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2026
  • Guj. Themis Bios - Board Meeting Intimation for Raising Funds Through Issue Of Non-Convertible Debentures By Way Of Private P

    7 Sep 2026, 8:03PM Gujarat Themis Biosyn Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/09/2026 ,inter alia, to conside
  • Guj. Themis Bios - Copy of Newspaper Publication

    7 Sep 2026, 2:53PM Gujarat Themis Biosyn Limited has informed the Exchange about Copy of Newspaper Publication of 45th AGM notice.
  • Guj. Themis Bios - Business Responsibility and Sustainability Reporting (BRSR)

    4 Sep 2026, 9:53PM Please refer to attached BRSR for F.Y. 2025-26
  • Guj. Themis Bios - Reg. 34 (1) Annual Report.

    4 Sep 2026, 9:50PM Please refer to our Annual Report for F.Y. 2025-26
  • Guj. Themis Bios - Shareholders Meeting - AGM On 30.09.2026

    4 Sep 2026, 9:36PM Please refer to the Notice of 45th Annual General Meeting scheduled on 30.09.2026
  • Guj. Themis Bios - Shareholders meeting

    4 Sep 2026, 9:16PM Gujarat Themis Biosyn Limited has informed the Exchange regarding Notice of 45th AGM to be held on September 30, 2026
  • Guj. Themis Bios - Outcome of Board Meeting

    1 Sep 2026, 4:15PM Gujarat Themis Biosyn Limited has informed the Exchange regarding Outcome of Board Meeting held on September 01, 2026.
  • Guj. Themis Bios - Board Meeting Outcome for Outcome Of The Board Meeting Held On 01-09-2026

    1 Sep 2026, 5:01PM Kindly refer to the outcome of the Board Meeting held on 01-09-2026
  • Guj. Themis Bios - Committee Meeting Updates

    28 Aug 2026, 11:33PM Gujarat Themis Biosyn Limited has informed the Exchange regarding Outcome of Committee Meeting held on August 28, 2026 for allot
  • Guj. Themis Bios - Announcement under Regulation 30 (LODR)-Allotment

    28 Aug 2026, 10:59PM Outcome of the Fund Raising Committee held on 28.08.2026 for allotment of equity shares through QIP
  • Guj. Themis Bios - General Updates

    28 Aug 2026, 9:04PM Gujarat Themis Biosyn Limited has informed the Exchange about the closure of QIP Issue.
  • Guj. Themis Bios - Announcement under Regulation 30 (LODR)-Qualified Institutional Placement

    28 Aug 2026, 8:42PM Outcome of Fund Raising Committee for QIP Issue Close
  • Guj. Themis Bios - Board Meeting Intimation for Intimation Of The Board Meeting

    27 Aug 2026, 6:40PM Gujarat Themis Biosyn Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/09/2026 ,inter alia, to conside
  • Guj. Themis Bios - General Updates

    25 Aug 2026, 11:30PM Gujarat Themis Biosyn Limited has informed the Exchange about General Updates - Outcome of Board meeting relating to QIP Issue.
  • Guj. Themis Bios - Board Meeting Outcome for Outcome Of Board Meeting Related To QIP

    25 Aug 2026, 11:30PM Please refer to the attachment
  • Guj. Themis Bios - General Updates

    25 Aug 2026, 9:53PM Gujarat Themis Biosyn Limited has informed the Exchange about General Updates
  • Guj. Themis Bios - Announcement Under Reg 30 (LODR) - Updates (Audited Financial Statements)

    25 Aug 2026, 9:35PM Please refer to our Announcement under Reg 30 (LODR) - Updates (Audited Financial Statements - F.Y. 2025-26)
  • Guj. Themis Bios - Amendment to AOA/MOA

    23 Aug 2026, 3:50PM Gujarat Themis Biosyn Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company.
  • Guj. Themis Bios - Amendment to AOA/MOA

    23 Aug 2026, 12:28PM Gujarat Themis Biosyn Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company.
  • Guj. Themis Bios - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association

    23 Aug 2026, 3:48PM Please refer to the attachment.
  • Guj. Themis Bios - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association

    23 Aug 2026, 12:25PM Please refer to the attachment.
  • Guj. Themis Bios - Shareholders meeting

    22 Aug 2026, 7:07PM Gujarat Themis Biosyn Limited has informed the Exchange regarding Proceedings of Postal Ballot. Further, the company has submitted the Exchange a copy
  • Guj. Themis Bios - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

    22 Aug 2026, 7:03PM Please refer to the attachment.
  • Guj. Themis Bios - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    22 Aug 2026, 7:00PM Please refer to the attachment.
  • Guj. Themis Bios - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    22 Aug 2026, 6:08PM Please refer to the attachment
  • Guj. Themis Bios - Shareholders meeting

    22 Aug 2026, 6:02PM Gujarat Themis Biosyn Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on August 22, 2026. Further, the c
  • Guj. Themis Bios - Shareholder Meeting / Postal Ballot-Outcome of EGM

    22 Aug 2026, 4:18PM Please refer to the outcome / proceedings of EGM held on 22.08.2026
  • Guj. Themis Bios Q1 net profit up 22.19% at Rs 11.07 cr

    21 Aug 2026, 11:00PM The company reported standalone net profit of Rs 11.07 crore for the quarter ended June 30, 2026 as compared to Rs 9.06 crore in the same period last
  • Guj. Themis Bios - Analysts/Institutional Investor Meet/Con. Call Updates

    14 Aug 2026, 11:53PM Gujarat Themis Biosyn Limited has informed the Exchange about Presentation and Transcript
  • Guj. Themis Bios - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    14 Aug 2026, 11:48PM Earnings Call Transcript
  • Guj. Themis Bios - Analysts/Institutional Investor Meet/Con. Call Updates

    10 Aug 2026, 8:16PM Gujarat Themis Biosyn Limited has informed the Exchange about Link of Recording
  • Guj. Themis Bios - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    10 Aug 2026, 8:10PM Please refer to our submission of Call Recordings of the investor/analyst Conference Call held on Monday, August 10, 2026 (IST).
  • Guj. Themis Bios - Copy of Newspaper Publication

    9 Aug 2026, 12:16AM Gujarat Themis Biosyn Limited has informed the Exchange about Copy of Newspaper Publication
  • Guj. Themis Bios - Investor Presentation

    7 Aug 2026, 5:16PM Gujarat Themis Biosyn Limited has informed the Exchange about Investor Presentation
  • Guj. Themis Bios - Announcement under Regulation 30 (LODR)-Investor Presentation

    7 Aug 2026, 5:06PM Please refer to our investors presentation for the quarter ended 30.06.2026
  • Guj. Themis Bios - Results- Unaudited Standalone And Consolidated Financial Results For The Quarter Ended 30Th June 2026

    7 Aug 2026, 2:59PM Please refer to the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June ,2026
  • Guj. Themis Bios - Outcome of Board Meeting

    7 Aug 2026, 1:12PM Gujarat Themis Biosyn Limited has submitted to the Exchange, the Unaudited standalone and consolidated financial Results for the period ended Jun 30
  • Guj. Themis Bios - Board Meeting Outcome for Outcome Of The Board Meeting Held On 07.08.2026

    7 Aug 2026, 12:59PM Please refer to the outcome of the Board meeting held on 07.08.2026
  • Guj. Themis Bios - Analysts/Institutional Investor Meet/Con. Call Updates

    4 Aug 2026, 8:48PM Gujarat Themis Biosyn Limited has informed the Exchange about Schedule of meet
  • Guj. Themis Bios - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    4 Aug 2026, 8:38PM Please refer to the concall invite to discuss the 1QFY27 Financial performance.
  • Guj. Themis Bios - Disclosure under SEBI Takeover Regulations

    4 Aug 2026, 7:02PM ÿSachin D. Patelÿhas submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition mad
  • Guj. Themis Bios - Copy of Newspaper Publication

    2 Aug 2026, 12:36AM Gujarat Themis Biosyn Limited has informed the Exchange about Copy of Newspaper Publication
  • Guj. Themis Bios - Shareholders meeting

    31 Jul 2026, 10:07PM Gujarat Themis Biosyn Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on August 22, 2026
  • Guj. Themis Bios - Notice Of Extra-Ordinary General Meeting On 22.08.2026

    31 Jul 2026, 10:02PM Please refer to the attachment.
  • Guj. Themis Bios - Board Meeting Intimation for Approval Of Un-Audited Financial Results And Limited Review Report Of Statuto

    31 Jul 2026, 9:19PM Gujarat Themis Biosyn Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to conside
  • Guj. Themis Bios - Disclosure under SEBI Takeover Regulations

    28 Jul 2026, 12:34PM CTL Trusteeship Ltdÿ has submitted to the Exchange a copy ofÿDisclosure under Regulation 29(1) of the Securities and Exchange Board of India (Substant
  • Guj. Themis Bios - Copy of Newspaper Publication

    24 Jul 2026, 2:00PM Gujarat Themis Biosyn Limited has informed the Exchange about Copy of Newspaper Publication for Postal Ballot.
  • Guj. Themis Bios - Shareholders meeting

    23 Jul 2026, 11:07PM Gujarat Themis Biosyn Limited has informed the Exchange regarding Notice of Postal Ballot dated 22.07.2026
  • Guj. Themis Bios - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    23 Jul 2026, 10:59PM Please refer to the Notice of Postal Ballot 22.07.2026

Key fundamentals

Evaluate the intrinsic value of Gujarat Themis Biosyn Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 447.6332 278.2718 201.376 149.1459 103.3214
Liabilities 447.6332 278.2718 201.376 149.1459 103.3214
Equity 10.8965 10.8965 7.2644 7.2644 7.2644
Gross Profit 75.5302 68.8444 78.7337 74.2174 58.0452
Net Profit 46.6815 48.7717 59.1632 57.9688 43.6242
Cash From Operating Activities 48.7773 91.0286 64.213 39.5009 40.3132
NPM(%) 28.15 32.34 34.83 38.91 37.98
Revenue 165.8228 150.7999 169.8219 148.9729 114.8539
Expenses 90.2926 81.9555 91.0882 74.7555 56.8087
ROE(%) 15.51 16.2 19.65 19.26 14.49

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
23 Sep 2026 0.67 67 0.21 389.35
04 Sep 2025 0.67 67 0.21 325.7

Peers

Other companies within the same industry or sector that are comparable to Gujarat Themis Biosyn Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 762.55 -2.77 19.29 202.66 -26.19 0.66
Lotus Eye Hospital and Institute Ltd 112.60 1.65 1608.57 738.48 0.39 0.00
Vaishali Pharma Ltd 6.80 -5.95 21.25 4632.71 15.42 0.00
Astec Lifesciences Ltd 667.00 -0.33 0.00 791.24 -363.14 0.00

Company Info

Gujarat Themis Biosyn Ltd. was incorporated in 1981 jointly by GIIC and chemosyn (P) Ltd. GIBL commenced production in Aug.1985 by producing antibiotic erythromycin, and erythromycin salts and formulations. GTBL was a sick company which was forced to discontinue production because of accumulated losses. The company was takenover during June 1991 by pharmaceutical Business Group India Ltd; a unique consortium of five competing drug companies - Themis Chemicals, Kopran, Anant & Co., Cadila and Lyka Labs. The company has technical and financial collaboration with Yuhan Corporation, South Korea. With Yuhan's knowhow, GTBL has become India's first company to start commercial production of anti-tubercolis drug, rifampicin. 2002-Gujarat Themis Biosyn Ltd has informed that Mr Rajneesh Anand has been appointed as the Managing Director of the Company w e f February 01, 2002. 2008 -Gujarat Themis Biosyn Ltd has appointed Mr. S S Lee as an Additional Director of the Company. -The Company has appointed Mr. Rajneesh Anand as Managing Director 2010 - Gujarat Themis Biosyn Ltd has appointed Mr. Subhash C Kaushik as Additional Director of the Company. 2011 -The Board of Directors appointed Mr. Rajneesh Anand as Managing Director of the Company 2012 -The Company has received a Rehabilitation Scheme approved by the Board of Industrial and Financial Reconstruction (BIFR) 2014 -Mr. Vikas Tarekar has been appointed as a Company Secretary of the company. -Mr. Tapas Guha has been appointed as a CEO of the Company. 2023 -The Company has splits its face value from Rs. 5/- to Rs. 1/-. 2024 -The Company has issued Bonus Shares in the Ratio of 1:2.-The Company has approved the Scheme of Amalgamation of Gujarat Themis Biosyn Ltd. with Themis Medicare Ltd.      2025-The Company has listed his 10,89,65,265 equity shares of face value of Rs.1/- each, fully paid up in National Stock Exchange (NSE)

Gujarat Themis Biosyn Ltd. was incorporated in 1981 jointly by GIIC and chemosyn (P) Ltd. GIBL commenced production in Aug.1985 by producing antibiotic erythromycin, and erythromycin salts and formulations. GTBL was a sick company which was forced to discontinue production because of accumulated losses. The company was takenover during June 1991 by pharmaceutical Business Group India Ltd; a unique consortium of five competing drug companies - Themis Chemicals, Kopran, Anant & Co., Cadila and Lyka Labs. The company has technical and financial collaboration with Yuhan Corporation, South Korea. With Yuhan's knowhow, GTBL has become India's first company to start commercial production of anti-tubercolis drug, rifampicin. 2002-Gujarat Themis Biosyn Ltd has informed that Mr Rajneesh Anand has been appointed as the Managing Director of the Company w e f February 01, 2002. 2008 -Gujarat Themis Biosyn Ltd has appointed Mr. S S Lee as an Additional Director of the Company. -The Company has appointed Mr. Rajneesh Anand as Managing Director 2010 - Gujarat Themis Biosyn Ltd has appointed Mr. Subhash C Kaushik as Additional Director of the Company. 2011 -The Board of Directors appointed Mr. Rajneesh Anand as Managing Director of the Company 2012 -The Company has received a Rehabilitation Scheme approved by the Board of Industrial and Financial Reconstruction (BIFR) 2014 -Mr. Vikas Tarekar has been appointed as a Company Secretary of the company. -Mr. Tapas Guha has been appointed as a CEO of the Company. 2023 -The Company has splits its face value from Rs. 5/- to Rs. 1/-. 2024 -The Company has issued Bonus Shares in the Ratio of 1:2.-The Company has approved the Scheme of Amalgamation of Gujarat Themis Biosyn Ltd. with Themis Medicare Ltd.      2025-The Company has listed his 10,89,65,265 equity shares of face value of Rs.1/- each, fully paid up in National Stock Exchange (NSE)

Parent Organisation

Gujarat Themis Biosyn Ltd.

Founded

11/12/1981

Managing Director

Dr.Sachin D Patel

NSE Symbol

GUJTHEMEQ

FAQ